David Windley analyst JEFFERIES

Currently out of the existing stock ratings of David Windley, 229 are a BUY (64.33%), 121 are a HOLD (33.99%), 6 are a SELL (1.69%).

David Windley

Work Performance Price Targets & Ratings Chart

Analyst David Windley, currently employed at JEFFERIES, carries an average stock price target met ratio of 71.29% that have a potential upside of 18.01% achieved within 336 days.

David Windley’s has documented 698 price targets and ratings displayed on 37 stocks. The coverage is on Healthcare, Basic Materials, Consumer Cyclical, Financial Services sectors.

Most recent stock forecast was given on MEDP, Medpace Holdings at 07-Jul-2026.

Wall Street Analyst David Windley

Analyst best performing recommendations are on NOTV (INOTIV).
The best stock recommendation documented was for NOTV (INOTIV) at 12/13/2023. The price target of $3 was fulfilled within 1 day with a profit of $0.24 (8.7%) receiving and performance score of 86.96.

Average potential price target upside

ANTM Anthem CERN Cerner Corp CERT Certara CI Cigna Corp CNC Centene Corp CRL Charles River Laboratories CTLT Catalent HMSY HMS Holdings Corp HUM Humana ICLR ICON PLC IQV IQVIA Holdings MOH Molina Healthcare SHC Sotera Health Co STVN Stevanato Group SpA TDOC Teladoc UNH UnitedHealth Group WCG WellCare Health Plans WST West Pharmaceutical Services MDRX Allscripts Healthcare Solutions SYNH Syneos Health ELV Elevance Health NOTV Inotiv MDSO Medidata Solutions MEDP Medpace Holdings Q Quintiles Transnational CE Celanese PRAH PRA Health Sciences VEEV Veeva Systems FTRE Fortrea Holdings NXGN Nextgen Healthcare DEO Diageo PLC ADR PPD PPD AN AutoNation ATHN athenahealth MD Mednax OSCR Oscar Health SLQT Selectquote

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 02-Jul-2021

$617

4 years 1 months 8 days ago
(22-Jun-2022)

4/6 (66.67%)

$95.47 (18.31%)

149

Buy Since 17-Jun-2022

$550

4 years 1 months 13 days ago
(17-Jun-2022)

0/1 (0%)

$95.24 (20.94%)

Buy Since 27-Apr-2017

$596

$113.42 (23.50%)

$574

4 years 2 months 3 days ago
(27-May-2022)

3/5 (60%)

$76.79 (14.79%)

741

Buy Since 19-May-2021

$580

$97.42 (20.19%)

$500

4 years 2 months 5 days ago
(25-May-2022)

3/4 (75%)

$76.52 (15.20%)

177

Buy Since 01-Nov-2018

$625

$142.42 (29.51%)

$510

4 years 3 months 5 days ago
(25-Apr-2022)

5/6 (83.33%)

$119.43 (23.62%)

427

Show more analysts

Please expand the browser size to see the chart

Which stock is David Windley is most bullish on?

Potential upside of $46.95 has been obtained for IQV (IQVIA HOLDINGS)

Which stock is David Windley is most reserved on?

Potential downside of -$154.32 has been obtained for HUM (HUMANA)

What Year was the first public recommendation made by David Windley?

On 2008

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?